Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.

Tytuł:
The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
Autorzy:
Kershaw V; Urogynaecology Department, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, United Kingdom. Electronic address: .
Hickey I; Department of Oncology and Metabolism, Sheffield University, Sheffield S10 2SJ, United Kingdom. Electronic address: .
Wyld L; Department of Oncology and Metabolism, Sheffield University, Sheffield S10 2SJ, United Kingdom. Electronic address: .
Jha S; Urogynaecology Department, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, United Kingdom. Electronic address: .
Źródło:
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2021 Oct; Vol. 265, pp. 7-17. Date of Electronic Publication: 2021 Aug 08.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
Język:
English
Imprint Name(s):
Publication: Limerick : Elsevier Scientific Publishers
Original Publication: Amsterdam, Excerpta Medica.
MeSH Terms:
Colorectal Neoplasms, Hereditary Nonpolyposis*
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/prevention & control
BRCA1 Protein/genetics ; Female ; Humans ; Mutation ; Retrospective Studies ; Salpingo-oophorectomy
Contributed Indexing:
Keywords: BRCA; Lynch syndrome; Oophorectomy; Risk-reducing; Sexual function
Substance Nomenclature:
0 (BRCA1 Protein)
0 (BRCA1 protein, human)
Entry Date(s):
Date Created: 20210820 Date Completed: 20211005 Latest Revision: 20211005
Update Code:
20240104
DOI:
10.1016/j.ejogrb.2021.08.001
PMID:
34416580
Czasopismo naukowe
Objective: In the absence of an effective screening test, women with a high genetic predisposition for ovarian cancer are recommended to undergo risk-reducing bilateral salpingo-oophorectomy (RRBSO) once childbearing is complete. This reduces the risk of ovarian cancer by up to 96%, but can result in undesirable side effects, including menopausal symptoms and sexual dysfunction. We have performed a systematic review and meta-analysis to investigate the effect of RRBSO on sexual function in women at high risk of breast/and or ovarian cancer.
Methods: A literature search of the AMED (Allied and complementary medicine), Embase and Medline databases was performed, using search terms including sexual function, risk reducing and oophorectomy. Results were filtered according to the PRISMA protocol. Quality assessment of studies was performed using the Newcastle-Ottawa scale. Data were pooled in meta-analysis.
Results: There were 21 eligible studies, 10 of which reported sufficient data for meta-analysis. Most studies were retrospective cohort or observational studies. Fifteen of the 21 studies (71%) reported a negative impact of RRBSO on sexual function. Participant numbers ranged from 37 to 1522. Meta-analysis was performed with studies including 3201 patients. This demonstrated that RRBSO has a statistically significant negative impact on sexual function (SMD -0.63, [-0.82, -0.44], p = 0.03). There was a trend towards reduced sexual pleasure and increased discomfort but this did not reach statistical significance. There was minimal change in the frequency of sex. There was a significant increase in vaginal dryness post-RRBSO (SMD 9.25, [3.66, 14.83], p < 0.00001). There was no significant difference in sexual function between pre-menopausal and post-menopausal RRBSO. Hormone replacement therapy (HRT) did not abolish this negative impact.
Conclusion: Sexual function declines post RRBSO, independent of menopausal status. Comprehensive pre-operative counselling regarding anticipated menopausal and sexual symptoms is key to setting realistic patient expectations and minimising post-operative distress. Information and support regarding management of these side effects should be available to all patients.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies